4D Path
PrivateLast Round
Strategic
May 5, 2026
Total Funding Raised
$4.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
4D Path operates in Healthcare & Life Sciences and is based in Newton, Massachusetts. Its latest recorded funding round was a Series A round in January 2023.
4D Path is a biotechnology company that has developed a patented, AI-powered precision diagnostics platform called the Q-Plasia OncoReader (QPOR™) to predict a patient's response to cancer treatment by analyzing digitized images from standard H&E-stained biopsies.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Clinical Trials, Medical Imaging, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4D Path Comparables
Compare 4D Path with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Waiv | 78% | |
| Tempus | 78% | |
| Indica Labs | 74% |
For institutional investors. Book with your work email.
4D Path Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 5, 2026 | ||||
| Series A | Jan 24, 2023 | ||||
| Seed | Dec 10, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
4D Path Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARTIS Ventures | Series A |
| Vesalius Biocapital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Completed a strategic funding round.
- Nov 12, 2025
Received the Boston Business Journal's Biotech Innovation Award.
For institutional investors. Book with your work email.
4D Path Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 4D Path's valuation, stock price, and market status.
Is 4D Path a public or private company?
4D Path is a private company.
What is the current stock price of 4D Path?
4D Path is a private company, so its shares have no public market price. Caplight tracks 4D Path's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 4D Path worth (valuation)?
Valuation information for 4D Path is not publicly available.
Can I buy 4D Path stock?
4D Path shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 4D Path's last funding round?
4D Path's most recent funding round was Strategic on May 5, 2026.
Who are the main investors in 4D Path?
Key investors in 4D Path include ARTIS Ventures.
Will 4D Path IPO soon?
No public IPO plans have been announced for 4D Path.
How can I track 4D Path secondary market activity?
Caplight tracks bids, offers, and trades in 4D Path's shares on secondary markets.